255 related articles for article (PubMed ID: 17250995)
1. Reviewing the role of the genes G72 and DAAO in glutamate neurotransmission in schizophrenia.
Boks MP; Rietkerk T; van de Beek MH; Sommer IE; de Koning TJ; Kahn RS
Eur Neuropsychopharmacol; 2007 Sep; 17(9):567-72. PubMed ID: 17250995
[TBL] [Abstract][Full Text] [Related]
2. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder.
Schumacher J; Jamra RA; Freudenberg J; Becker T; Ohlraun S; Otte AC; Tullius M; Kovalenko S; Bogaert AV; Maier W; Rietschel M; Propping P; Nöthen MM; Cichon S
Mol Psychiatry; 2004 Feb; 9(2):203-7. PubMed ID: 14966479
[TBL] [Abstract][Full Text] [Related]
3. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia.
Chumakov I; Blumenfeld M; Guerassimenko O; Cavarec L; Palicio M; Abderrahim H; Bougueleret L; Barry C; Tanaka H; La Rosa P; Puech A; Tahri N; Cohen-Akenine A; Delabrosse S; Lissarrague S; Picard FP; Maurice K; Essioux L; Millasseau P; Grel P; Debailleul V; Simon AM; Caterina D; Dufaure I; Malekzadeh K; Belova M; Luan JJ; Bouillot M; Sambucy JL; Primas G; Saumier M; Boubkiri N; Martin-Saumier S; Nasroune M; Peixoto H; Delaye A; Pinchot V; Bastucci M; Guillou S; Chevillon M; Sainz-Fuertes R; Meguenni S; Aurich-Costa J; Cherif D; Gimalac A; Van Duijn C; Gauvreau D; Ouellette G; Fortier I; Raelson J; Sherbatich T; Riazanskaia N; Rogaev E; Raeymaekers P; Aerssens J; Konings F; Luyten W; Macciardi F; Sham PC; Straub RE; Weinberger DR; Cohen N; Cohen D
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13675-80. PubMed ID: 12364586
[TBL] [Abstract][Full Text] [Related]
4. Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.
Frattini LF; Piubelli L; Sacchi S; Molla G; Pollegioni L
FEBS J; 2011 Nov; 278(22):4362-73. PubMed ID: 21981077
[TBL] [Abstract][Full Text] [Related]
5. Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.
Williams M
Biochem Pharmacol; 2009 Dec; 78(11):1360-5. PubMed ID: 19591808
[TBL] [Abstract][Full Text] [Related]
6. Association analyses of the DAOA/G30 and D-amino-acid oxidase genes in schizophrenia: further evidence for a role in schizophrenia.
Shinkai T; De Luca V; Hwang R; Müller DJ; Lanktree M; Zai G; Shaikh S; Wong G; Sicard T; Potapova N; Trakalo J; King N; Matsumoto C; Hori H; Wong AH; Ohmori O; Macciardi F; Nakamura J; Kennedy JL
Neuromolecular Med; 2007; 9(2):169-77. PubMed ID: 17627036
[TBL] [Abstract][Full Text] [Related]
7. No association of G72 and D-amino acid oxidase genes with schizophrenia.
Liu YL; Fann CS; Liu CM; Chang CC; Wu JY; Hung SI; Liu SK; Hsieh MH; Hwang TJ; Chan HY; Chen JJ; Faraone SV; Tsuang MT; Chen WJ; Hwu HG
Schizophr Res; 2006 Oct; 87(1-3):15-20. PubMed ID: 16842973
[TBL] [Abstract][Full Text] [Related]
8. Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.
Strick CA; Li C; Scott L; Harvey B; Hajós M; Steyn SJ; Piotrowski MA; James LC; Downs JT; Rago B; Becker SL; El-Kattan A; Xu Y; Ganong AH; Tingley FD; Ramirez AD; Seymour PA; Guanowsky V; Majchrzak MJ; Fox CB; Schmidt CJ; Duplantier AJ
Neuropharmacology; 2011; 61(5-6):1001-15. PubMed ID: 21763704
[TBL] [Abstract][Full Text] [Related]
9. Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels.
Yamada K; Ohnishi T; Hashimoto K; Ohba H; Iwayama-Shigeno Y; Toyoshima M; Okuno A; Takao H; Toyota T; Minabe Y; Nakamura K; Shimizu E; Itokawa M; Mori N; Iyo M; Yoshikawa T
Biol Psychiatry; 2005 Jun; 57(12):1493-503. PubMed ID: 15953485
[TBL] [Abstract][Full Text] [Related]
10. G72 gene is associated with susceptibility to methamphetamine psychosis.
Kotaka T; Ujike H; Okahisa Y; Takaki M; Nakata K; Kodama M; Inada T; Yamada M; Uchimura N; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1046-9. PubMed ID: 19482054
[TBL] [Abstract][Full Text] [Related]
11. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
Yang CR; Svensson KA
Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
[TBL] [Abstract][Full Text] [Related]
12. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
13. [Glutamatergic neurotransmission in schizophrenics].
Bleich S; Bleich K; Wiltfang J; Maler JM; Kornhuber J
Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S56-61. PubMed ID: 11533851
[TBL] [Abstract][Full Text] [Related]
14. Contributions of the D-serine pathway to schizophrenia.
Labrie V; Wong AH; Roder JC
Neuropharmacology; 2012 Mar; 62(3):1484-503. PubMed ID: 21295046
[TBL] [Abstract][Full Text] [Related]
15. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.
Madeira C; Freitas ME; Vargas-Lopes C; Wolosker H; Panizzutti R
Schizophr Res; 2008 Apr; 101(1-3):76-83. PubMed ID: 18378121
[TBL] [Abstract][Full Text] [Related]
16. Genetic vulnerability to psychosis and cortical function: epistatic effects between DAAO and G72.
Mechelli A; Prata D; Papagni SA; Tognin S; Kambeitz J; Fu C; Picchioni M; Walshe M; Toulopoulou T; Bramon E; Murray R; McGuire P
Curr Pharm Des; 2012; 18(4):510-7. PubMed ID: 22239582
[TBL] [Abstract][Full Text] [Related]
17. Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.
Cherlyn SY; Woon PS; Liu JJ; Ong WY; Tsai GC; Sim K
Neurosci Biobehav Rev; 2010 May; 34(6):958-77. PubMed ID: 20060416
[TBL] [Abstract][Full Text] [Related]
18. The behavioral and neurochemical effects of a novel D-amino acid oxidase inhibitor compound 8 [4H-thieno [3,2-b]pyrrole-5-carboxylic acid] and D-serine.
Smith SM; Uslaner JM; Yao L; Mullins CM; Surles NO; Huszar SL; McNaughton CH; Pascarella DM; Kandebo M; Hinchliffe RM; Sparey T; Brandon NJ; Jones B; Venkatraman S; Young MB; Sachs N; Jacobson MA; Hutson PH
J Pharmacol Exp Ther; 2009 Mar; 328(3):921-30. PubMed ID: 19088300
[TBL] [Abstract][Full Text] [Related]
19. The G72/G30 gene complex and cognitive abnormalities in schizophrenia.
Goldberg TE; Straub RE; Callicott JH; Hariri A; Mattay VS; Bigelow L; Coppola R; Egan MF; Weinberger DR
Neuropsychopharmacology; 2006 Sep; 31(9):2022-32. PubMed ID: 16554747
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia.
Hashimoto K; Fukushima T; Shimizu E; Komatsu N; Watanabe H; Shinoda N; Nakazato M; Kumakiri C; Okada S; Hasegawa H; Imai K; Iyo M
Arch Gen Psychiatry; 2003 Jun; 60(6):572-6. PubMed ID: 12796220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]